Vilar-Gomez, E. I. I., Gawrieh, S., Lake, J. E., Woreta, T. A., Releford, M., Sulkowski, M. S., … Chalasani, N. P. (2023). AMONG PEOPLE WITH HIV, NON-HISPANIC BLACKS HAVE A SIGNIFICANTLY LOWER PREVALENCE OF NAFLD AND CLINICALLY SIGNIFICANT FIBROSIS. In HEPATOLOGY (Vol. 78, pp. S916–S918).

Vilar-Gomez, Eduardo I. I., Samer Gawrieh, Jordan E. Lake, Tinsay A. Woreta, Montreca Releford, Mark S. Sulkowski, Rohit Loomba, et al. “AMONG PEOPLE WITH HIV, NON-HISPANIC BLACKS HAVE A SIGNIFICANTLY LOWER PREVALENCE OF NAFLD AND CLINICALLY SIGNIFICANT FIBROSIS.” In HEPATOLOGY, 78:S916–18, 2023.

Vilar-Gomez EII, Gawrieh S, Lake JE, Woreta TA, Releford M, Sulkowski MS, et al. AMONG PEOPLE WITH HIV, NON-HISPANIC BLACKS HAVE A SIGNIFICANTLY LOWER PREVALENCE OF NAFLD AND CLINICALLY SIGNIFICANT FIBROSIS. In: HEPATOLOGY. 2023. p. S916–8.

Vilar-Gomez, Eduardo I. I., et al. “AMONG PEOPLE WITH HIV, NON-HISPANIC BLACKS HAVE A SIGNIFICANTLY LOWER PREVALENCE OF NAFLD AND CLINICALLY SIGNIFICANT FIBROSIS.” HEPATOLOGY, vol. 78, 2023, pp. S916–18.

Vilar-Gomez EII, Gawrieh S, Lake JE, Woreta TA, Releford M, Sulkowski MS, Loomba R, Price JC, Corey KE, Naggie S, Heath S, Wilson L, Sterling RK, Chalasani NP. AMONG PEOPLE WITH HIV, NON-HISPANIC BLACKS HAVE A SIGNIFICANTLY LOWER PREVALENCE OF NAFLD AND CLINICALLY SIGNIFICANT FIBROSIS. HEPATOLOGY. 2023. p. S916–S918.